Dr. Setia is a surgical pathologist with a subspecialty focus in gastrointestinal pathology.
Massachusetts General Hospital/Harvard Medical School
Fellowship - Gastrointestional Pathology
2014
Baystate Medical Center/Tufts University School of Medicine
Fellowship - Cytopathology
2013
Brigham and Women's Hospital/Harvard Medical School
Boston
Fellowship - Surigal Pathology
2012
Baystate Medical Center/Tufts University School of Medicine
MD
2008
Maulana Azad Medical College
New Delhi, India
MD
2004
Lady Hardings Medical College
New Delhi, India
MBBS
1997
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Aug 01.
PMID: 39093924
Follow-up biopsies in gastrointestinal immune checkpoint inhibitor toxicity may show markedly different inflammatory patterns than initial injury.
Follow-up biopsies in gastrointestinal immune checkpoint inhibitor toxicity may show markedly different inflammatory patterns than initial injury. Hum Pathol. 2024 Jun; 148:60-65.
PMID: 38734079
High risk features in colorectal adenomatous polyps: A multi-institutional study.
High risk features in colorectal adenomatous polyps: A multi-institutional study. Ann Diagn Pathol. 2024 Oct; 72:152323.
PMID: 38733674
Esophageal squamous cell carcinoma with pagetoid spread: a clinicopathologic study.
Esophageal squamous cell carcinoma with pagetoid spread: a clinicopathologic study. Virchows Arch. 2024 Apr 26.
PMID: 38671319
A novel telomere biology disease-associated gastritis identified through a whole exome sequencing-driven approach.
A novel telomere biology disease-associated gastritis identified through a whole exome sequencing-driven approach. J Pathol Clin Res. 2024 Jan; 10(1):e349.
PMID: 37994393
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases.
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases. Am J Surg. 2024 Mar; 229:17-23.
PMID: 37802701
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment.
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment. Res Sq. 2023 Aug 01.
PMID: 37577519
Endoscopic Ultrasound Predicts Risk of Occult Intra-Abdominal Metastases in Localized Gastric Cancer: A Validation Study.
Endoscopic Ultrasound Predicts Risk of Occult Intra-Abdominal Metastases in Localized Gastric Cancer: A Validation Study. Gastroenterology Res. 2023 Feb; 16(1):9-16.
PMID: 36895700
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs.
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs. Surg Pathol Clin. 2023 Mar; 16(1):131-150.
PMID: 36739160
Measuring the Submucosal Depth of Invasion in Endoscopic Mucosal Resections for Barrett-associated Adenocarcinoma: Practical Issues and Relevance for the Decision for Esophagectomy.
Measuring the Submucosal Depth of Invasion in Endoscopic Mucosal Resections for Barrett-associated Adenocarcinoma: Practical Issues and Relevance for the Decision for Esophagectomy. Arch Pathol Lab Med. 2022 11 01; 146(11):1338-1344.
PMID: 35213893